422 related articles for article (PubMed ID: 33321259)
21. A Spin-Tip Enrichment Strategy for Simultaneous Analysis of N-Glycopeptides and Phosphopeptides from Human Pancreatic Tissues.
Tabang DN; Wang D; Li L
J Vis Exp; 2022 May; (183):. PubMed ID: 35604151
[TBL] [Abstract][Full Text] [Related]
22. Visualization of the dynamics of histone modifications and their crosstalk using PTM-CrossTalkMapper.
Kirsch R; Jensen ON; Schwämmle V
Methods; 2020 Dec; 184():78-85. PubMed ID: 31978537
[TBL] [Abstract][Full Text] [Related]
23. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques.
Zhao Y; Jensen ON
Proteomics; 2009 Oct; 9(20):4632-41. PubMed ID: 19743430
[TBL] [Abstract][Full Text] [Related]
24. Novel Strategies to Address the Challenges in Top-Down Proteomics.
Melby JA; Roberts DS; Larson EJ; Brown KA; Bayne EF; Jin S; Ge Y
J Am Soc Mass Spectrom; 2021 Jun; 32(6):1278-1294. PubMed ID: 33983025
[TBL] [Abstract][Full Text] [Related]
25. Deciphering combinatorial post-translational modifications by top-down mass spectrometry.
Brodbelt JS
Curr Opin Chem Biol; 2022 Oct; 70():102180. PubMed ID: 35779351
[TBL] [Abstract][Full Text] [Related]
26. Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.
Zhan X; Huang Y; Long Y
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29658936
[TBL] [Abstract][Full Text] [Related]
27. Combinatorial degradomics: Precision tools to unveil proteolytic processes in biological systems.
Savickas S; Kastl P; Auf dem Keller U
Biochim Biophys Acta Proteins Proteom; 2020 Jun; 1868(6):140392. PubMed ID: 32087360
[TBL] [Abstract][Full Text] [Related]
28. Multiplexed quantitative phosphoproteomics of cell line and tissue samples.
Kreuzer J; Edwards A; Haas W
Methods Enzymol; 2019; 626():41-65. PubMed ID: 31606085
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of human salivary gland-derived intact proteome using top-down mass spectrometry.
Wu S; Brown JN; Tolić N; Meng D; Liu X; Zhang H; Zhao R; Moore RJ; Pevzner P; Smith RD; Paša-Tolić L
Proteomics; 2014 May; 14(10):1211-22. PubMed ID: 24591407
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Unknown Posttranslational Modifications by Top-Down Mass Spectrometry.
Wilson JW; Zhou M
Methods Mol Biol; 2022; 2500():181-199. PubMed ID: 35657594
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenoma nitroproteomics: current status and perspectives.
Zhan X; Wang X; Desiderio DM
Oxid Med Cell Longev; 2013; 2013():580710. PubMed ID: 23533694
[TBL] [Abstract][Full Text] [Related]
32. Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms.
Schaffer LV; Tucholski T; Shortreed MR; Ge Y; Smith LM
Anal Chem; 2019 Sep; 91(17):10937-10942. PubMed ID: 31393705
[TBL] [Abstract][Full Text] [Related]
33. The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).
Yakubu RR; Nieves E; Weiss LM
Adv Exp Med Biol; 2019; 1140():169-198. PubMed ID: 31347048
[TBL] [Abstract][Full Text] [Related]
34. Characterizing Age-related Changes in Intact Mitochondrial Proteoforms in Murine Hearts using Quantitative Top-Down Proteomics.
Ramirez-Sagredo A; Sunny A; Cupp-Sutton K; Chowdhury T; Zhao Z; Wu S; Ann Chiao Y
Res Sq; 2024 Jan; ():. PubMed ID: 38313302
[TBL] [Abstract][Full Text] [Related]
35. Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.
Zhan X; Evans CO; Oyesiku NM; Desiderio DM
Pituitary; 2003; 6(4):189-202. PubMed ID: 15237930
[TBL] [Abstract][Full Text] [Related]
36. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
[TBL] [Abstract][Full Text] [Related]
37. Complete posttranslational modification mapping of pathogenic Neisseria meningitidis pilins requires top-down mass spectrometry.
Gault J; Malosse C; Machata S; Millien C; Podglajen I; Ploy MC; Costello CE; Duménil G; Chamot-Rooke J
Proteomics; 2014 May; 14(10):1141-51. PubMed ID: 24459079
[TBL] [Abstract][Full Text] [Related]
38. Quantifying Homologous Proteins and Proteoforms.
Malioutov D; Chen T; Airoldi E; Jaffe J; Budnik B; Slavov N
Mol Cell Proteomics; 2019 Jan; 18(1):162-168. PubMed ID: 30282776
[TBL] [Abstract][Full Text] [Related]
39. High-Throughput Quantitative Top-Down Proteomics: Histone H4.
Holt MV; Wang T; Young NL
J Am Soc Mass Spectrom; 2019 Dec; 30(12):2548-2560. PubMed ID: 31741267
[TBL] [Abstract][Full Text] [Related]
40. The next level of complexity: crosstalk of posttranslational modifications.
Venne AS; Kollipara L; Zahedi RP
Proteomics; 2014 Mar; 14(4-5):513-24. PubMed ID: 24339426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
